Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ASND
Recent news which mentions ASND
< Previous
1
2
3
4
5
Next >
Ascendis Seeks FDA Nod For TransCon PTH In Adults With Hypoparathyroidism
August 31, 2022
Tickers
ASND
Tags
NDA Submission
ASND
Benzinga
From
Benzinga
Expert Ratings for Ascendis Pharma
August 30, 2022
Tickers
ASND
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
Oppenheimer Maintains Outperform Rating for Ascendis Pharma: Here's What You Need To Know
August 11, 2022
Tickers
ASND
Tags
Market News
Analyst Ratings
BZI/AAR/UPDATE
From
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Tickers
ADMP
AEMD
ALPN
ARDS
Tags
IBB
VYNE
ARDS
From
Benzinga
What 14 Analyst Ratings Have To Say About Ascendis Pharma
May 12, 2022
Tickers
ASND
Tags
Benzinga
ASND
BZI/AAR
From
Benzinga
Why Ascendis Pharma Stock Is Sinking Today
May 12, 2022
Tickers
ASND
Tags
Recent Press Releases
ASND
Market News
From
Motley Fool
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
March 24, 2022
Tickers
AHPA
APLS
ASND
ATHA
Tags
MRK
TFFP
HOOK
From
Benzinga
BofA Upgrades Ascendis Pharma After Promising TCP Phase 3 Data
March 15, 2022
Tickers
ASND
Tags
Price Target
BofA Securities
Upgrades
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022
March 15, 2022
Tickers
AL
ASND
BIGC
BIVI
Tags
ZYME
BZI/Ratings
BIVI
From
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 14, 2022
Tickers
ASND
AVGR
CLSD
ERYP
Tags
Pre/Market Outlook
Movers
LEGN
From
Benzinga
10 Biggest Price Target Changes For Monday
March 14, 2022
Tickers
ASND
AVDX
COCO
GIII
Tags
COCO
Benzinga
GIII
From
Benzinga
Ascendis Pharma's Hypoparathyroidism Trial Meets Primary, Secondary Endpoints
March 14, 2022
Tickers
ASND
Tags
Briefs
News
Biotech
From
Benzinga
7 Biotech Stocks With Key Catalysts in March
March 09, 2022
Tickers
AKBA
AMLX
ARNA
ASND
Tags
ASND
SPY
IMRA
From
InvestorPlace
Expert Ratings For Ascendis Pharma
March 07, 2022
Tickers
ASND
Tags
BZI/AAR
ASND
Benzinga
From
Benzinga
The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO
March 03, 2022
Tickers
AMPE
ASND
ATRS
BGNE
Tags
ATRS
Market News
EVFM
From
Benzinga
Earnings Scheduled For March 2, 2022
March 02, 2022
Tickers
AEO
AI
AMRX
ANF
Tags
ORN
SPLK
MRAM
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
March 01, 2022
Tickers
ACLX
ACVA
ALNY
AMED
Tags
WHD
Analyst Ratings
LII
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022
February 14, 2022
Tickers
AGNC
ALL
ANET
ASND
Tags
Analyst Ratings
ALL
CRNC
From
Benzinga
Where Ascendis Pharma Stands With Analysts
January 27, 2022
Tickers
ASND
Tags
Benzinga
ASND
BZI/AAR
From
Benzinga
Ascendis Pharma's Growth Hormone Deficiency Med Scores European Approval
January 13, 2022
Tickers
ASND
Tags
Health Care
General
Biotech
From
Benzinga
Where Ascendis Pharma Stands With Analysts
January 06, 2022
Tickers
ASND
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022
January 06, 2022
Tickers
ADGI
ADT
AEIS
AKAM
Tags
TGT
CDAY
GS
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
December 08, 2021
Tickers
ALLE
ALLT
AMPL
APLS
Tags
ALLT
SFIX
Analyst Ratings
From
Benzinga
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
November 19, 2021
Tickers
ASND
BMY
CADL
CNTB
Tags
ASND
CADL
General
From
Benzinga
Ascendis' Hypoparathyroidism Candidate Shows Durable Benefit At 84 Weeks
November 19, 2021
Tickers
ASND
Tags
FDA
Benzinga
ASND
From
Benzinga
10 Biggest Price Target Changes For Monday
November 15, 2021
Tickers
ASND
BTAI
CARG
EVGO
Tags
Small Cap
RXDX
Penny Stocks
From
Benzinga
Analyst Ratings For Ascendis Pharma
November 11, 2021
Tickers
ASND
Tags
Benzinga
ASND
BZI/AAR
From
Benzinga
Ascendis Pharma A/S (ASND) Q3 2021 Earnings Call Transcript
November 10, 2021
Tickers
ASND
Tags
Market News
ASND
Recent Press Releases
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021
October 20, 2021
Tickers
AGL
APO
ARRY
ASND
Tags
SEDG
ARRY
SHLS
From
Benzinga
This Growth Hormone Drug Could Be a Boost For Pfizer
October 05, 2021
Tickers
ASND
OPK
PFE
Tags
ASND
PFE
Market News
From
Motley Fool
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.